Dr. Charles Louis Wiseman, MD

  • Visalia, CA
  • Medical oncologist
NPI1962493551
Part D claims, 2020
11
Publications
22
Clinical trials
2
Industry payments
$1,246
State licenses
4
Practice address
400 W Mineral King Ave, Visalia, CA 93291
Practice phone
Call (323) 377-4741
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Wiseman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Charles Louis Wiseman is a medical oncologist in Visalia, California

Dr. Wiseman practices in Visalia, California.

Dr. Wiseman's NPI, 1962493551, was assigned on November 2, 2005. Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969. Dr. Wiseman holds California license A24132.

NPI and contact details
NPI enumeration date
November 2, 2005
NPI status
Active
Practice phone
(323) 377-4741
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1969

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Charles Louis Wiseman's practice address is in Visalia, California

Dr. Wiseman's practice address in the NPI Registry is 400 W Mineral King Ave, Visalia, CA 93291, in Tulare County. The practice phone is (323) 377-4741.

  • NPI Registry address
    400 W Mineral King Ave, Visalia, CA 93291 · Tulare CountyPhone(323) 377-4741

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Charles Louis Wiseman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wiseman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Wiseman's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Wiseman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Charles Louis Wiseman is one of 415 medical oncologists in California

Medical oncology is Dr. Wiseman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Wiseman's licenses on file in 4 states: California, Florida, Texas and Louisiana.

Specialties and state licenses

  • Medical oncology, CaliforniaPrimaryLicense A24132 · 1971 to 2026 · taxonomy 207RX0202X
  • Florida license2016 to 2018
  • Texas license1973 to 1980
  • Louisiana license1974 to 1975

Medical oncologists near Dr. Wiseman

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

415medical oncologists in California
2medical oncologists in Visalia

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Charles Louis Wiseman wrote 11 Medicare Part D claims in 2020

In 2020, Dr. Wiseman wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $22,249 in total drug cost. In 2019, CMS named 63 claims across 5 drugs.

Part D claims, 202011
Drugs named by CMS1
Total drug cost$22,249

Dr. Wiseman's most prescribed drugs by claims, 2020

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2019 to 2020

  • 2019
  • 2020
Claims for drugs CMS names
2019: 632020: 1183%

Drugs named by CMS: 1 in 2020, 5 in 2019.

See all prescribing by Dr. Wiseman

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Wiseman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Charles Louis Wiseman has 22 publications on record

Dmand AI links 22 papers to Dr. Wiseman, published from 2003 to 2018. The most frequent topics are Breast Neoplasms, Drug Evaluation and Antineoplastic Agents. Dr. Wiseman has published most often in Cancer. Dr. Wiseman's most frequent co-authors are Cary A. Presant, MD, Douglas W. Blayney, MD and George R. Blumenschein, MD.

Papers22
Years published2003 to 2018

Topics Dr. Wiseman writes about most

  • Breast Neoplasms
  • Drug Evaluation
  • Antineoplastic Agents
  • Cancer Vaccines
  • Doxorubicin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Nausea
  • Neoplasm Metastasis

Dr. Wiseman's most frequent co-authors

Recent publications by Dr. Wiseman

See all 22 publications and co-authors

See who Dr. Wiseman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wiseman works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Charles Louis Wiseman has worked on 2 clinical trials

Dmand AI links Dr. Wiseman to 2 clinical trials. Conditions studied include Breast Neoplasms, Male, Mesothelioma, Malignant and Breast Neoplasms.

Clinical trials with Dr. Wiseman by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 1Phase 2: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Wiseman's trials

  • Breast Neoplasms, Male
  • Mesothelioma, Malignant
  • Breast Neoplasms
  • Pleural Neoplasms

Recent clinical trials with Dr. Wiseman

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Charles Louis Wiseman received $1,246 in industry payments from 2016 to 2020

CMS Open Payments shows 55 general payments to Dr. Wiseman from 14 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $443.

General payments to Dr. Wiseman by program year, 2016 to 2020

Companies that paid Dr. Wiseman the most, 2016 to 2020

Share is of all general payments to this clinician.

See all payments to Dr. Wiseman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Charles Louis Wiseman has 1 award and honors on record

Dmand AI lists 1 award for Dr. Wiseman, most recently Founder and Director in 2016.

Awards and honors for Dr. Wiseman

  1. 2016
    • Founder and Director

Source: Dmand AI Professional Profile Data

Dr. Charles Louis Wiseman graduated from David Geffen School of Medicine at UCLA

Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969.

  1. Medical schoolDavid Geffen School of Medicine at UCLA

Source: Dmand AI Professional Profile Data

Sources for Dr. Charles Louis Wiseman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Charles Louis Wiseman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Charles Louis Wiseman's NPI number?

Dr. Charles Louis Wiseman's NPI number is 1962493551. It was assigned on November 2, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Charles Louis Wiseman?

Dr. Charles Louis Wiseman is a medical oncologist in Visalia, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Charles Louis Wiseman practice?

Dr. Wiseman practices at 400 W Mineral King Ave, Visalia, CA 93291.

What is Dr. Charles Louis Wiseman's office phone number?

The practice phone on file for Dr. Wiseman is (323) 377-4741.

What is Dr. Charles Louis Wiseman's medical license number?

Dr. Wiseman holds California license A24132, one of the licenses on file in 4 states.

Which states has Dr. Charles Louis Wiseman been licensed in?

Dmand AI has state licenses on file for Dr. Wiseman in California (1971 to 2026), Florida (2016 to 2018), Texas (1973 to 1980) and Louisiana (1974 to 1975).

Where did Dr. Charles Louis Wiseman go to medical school?

Dr. Wiseman graduated from David Geffen School of Medicine at UCLA in 1969.

What drugs does Dr. Charles Louis Wiseman prescribe most?

In 2020 Medicare Part D data, Dr. Wiseman's most prescribed drugs by claims were Voriconazole.

Has Dr. Charles Louis Wiseman received payments from drug or device companies?

CMS Open Payments shows $1,246 in general payments to Dr. Wiseman from 14 companies from 2016 to 2020. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Charles Louis Wiseman been practicing?

Dr. Wiseman graduated from medical school in 1969, 57 years ago.

Does Dr. Charles Louis Wiseman do research?

Dmand AI links 22 publications to Dr. Wiseman, published from 2003 to 2018. Dr. Wiseman has worked on 2 clinical trials.

Who does Dr. Charles Louis Wiseman publish with?

Dr. Wiseman's most frequent co-authors are Cary A. Presant, MD (7 shared papers), Douglas W. Blayney, MD (6 shared papers) and George R. Blumenschein, MD (4 shared papers).

Selling to medical oncology practices?

See medical oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)